We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Proteinuria Determined by Automated Analyzer

By LabMedica International staff writers
Posted on 03 Jul 2012
A rapid, accurate, and cost-effective method for their detection of protein in urine has been developed for the autoanalyzer. More...


The method is a two-reagent system consists of a buffer solution and surfactants, and a second one consists of a dye solution of Erythrosin B being added to a urine sample, and the dye bound protein is measured by a spectrophotometer.

At the Juntendo University (Tokyo, Japan) nephrologists enrolled 70 outpatients who were screened for proteinuria by the dipstick test. Spot urine samples from the patients and 79 healthy volunteers were examined. Urine samples were stored at -80 °C. A solution containing a buffer agent with a pH 2.3 and surfactants and a solution of Erythrosin B are added to each urine sample. After letting the mixture stand for five minutes at 37 °C, the dye-bound protein is measured by a spectrophotometer at 546 nm using an automated analyzer.

The calibration curve was linear with human serum albumin concentration in the range of 2.4-200 mg/L. The detection limit, 2.4 mg/L was superior to conventional dye-binding methods by one order of magnitude and comparable to the turbidimetric immunoassay (TIA), which is quite expensive. There was an excellent correlation between the results given by the Erythrosin B (Wako Pure Chemical Industries Ltd., Tokyo, Japan) method and those by the TIA.

The authors concluded that the method is equal to the dipstick test in terms of time and cost savings. The reaction was completed within 5 minutes at 37 °C after mixing the test solution, and could be coupled with the 7170S automated analyzer (Hitachi, Tokyo, Japan) for rapid detection. The method was capable of determining actual samples without being influenced by foreign substances in urine such as urea, creatinine, and glucose. This method is sufficiently sensitive for the detection of trace proteinuria in early-stage of chronic kidney disease, and is directly applicable to actual samples. The study was published in the July 2012 issue of the journal Clinica Chimica Acta.

Related Links:

Juntendo University
Wako Pure Chemical Industries Ltd.
Hitachi




New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Integrated Biochemical & Immunological System
Biolumi CX8
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.